A Novel c-Mesenchymal-Epithelial Transition Factor Intergenic Fusion Response to Crizotinib in a Chinese Patient With Lung Adenocarcinoma: A Case Report
Hongge Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinlin Mu(Peking University), Zhang Moqin(Peking University), Zhancheng Gao(Xiamen University), Dexun Zhou(Peking University), Lin Dai(Peking University)
Cited by 4
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
<p>MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis</p>
|OncoTargets and Therapy|2020|111
PI3K in Cancer: Its Structure, Activation Modes and Role in Shaping Tumor Microenvironment
|Future Oncology|2017|65
Global outbreak research: harmony not hegemony
|The Lancet Infectious Diseases|2020|56
Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment
|OncoTargets and Therapy|2018|55